Mar 2026 $10 M Private placement after listing $10 to $50 million 16
RenovoRx, Inc.: Private sale, Mar 2026 × Investors in this round 16 investors had bought by the notice of Apr 9, 2026: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken $10,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions $549,996
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Leesa R. Gentry · Executive Officer Mark R. Voll · Executive Officer Ramtin R. Agah · Executive Officer Shaun R. Bagai · Executive Officer, Director Kirsten Angela Macfarlane · Director Laurence J. Marton · Director Robert J. Spiegel · Director Una S. Ryan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round T.R. WINSTON & COMPANY, LLC (CRD 10571) · Bedminster, New Jersey Sold in all US states Remarks in the notice On the amounts: “The offering is closed.”Signed by Shaun R. Bagai, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Apr 9, 2026. Read the notice at the SEC .
equity, options SEC Apr 2024 $11 M Private placement after listing $10 to $50 million 172
RenovoRx, Inc.: Private sale, Apr 2024 × Investors in this round 172 investors had bought by the notice of Apr 22, 2024: 172 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $15 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $1,280,937
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Leesa B. Gentry · Executive Officer Ramtin R. Agah · Executive Officer, Director Ronald B. Kocak · Executive Officer Shaun R. Bagai · Executive Officer, Director Kirsten Angela Macfarlane · Director Laurence J. Marton · Director Robert S. Spiegel · Director Una S. Ryan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Newbridge Securities Corporation (CRD 104065) · Boca Raton, Florida Sold in all US states Remarks in the notice On the amounts: “The offering is closed.”Signed by Shaun R. Bagai, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Apr 22, 2024. Read the notice at the SEC .
equity, options SEC Jan 2024 $6 M Private placement after listing $2 to $10 million 92
RenovoRx, Inc.: Private sale, Jan 2024 × Investors in this round 92 investors had bought by the notice of Feb 9, 2024: 92 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $15 M offered; $9 M still to sell
Smallest investment taken $10,000
What was sold equity Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $508,043
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Angela Gill Nelms · Executive Officer Ramtin R. Agah · Executive Officer, Director Ron R. Kocak · Executive Officer Shaun R. Bagai · Executive Officer, Director Kirsten Angela Macfarlane · Director Laurence J. Marton · Director Robert S. Spiegel · Director Una S. Ryan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round PAULSON INVESTMENT COMPANY LLC (CRD 5670) · Portland, Oregon Sold in all US states Signed by Shaun R. Bagai, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Feb 9, 2024. Read the notice at the SEC .
equity SEC Apr 2018 $8 M No. 3 $2 to $10 million 21
RenovoRx, Inc.: Raise no. 3, Apr 2018 × Investors in this round 21 investors had bought by the notice of Jun 19, 2018: 21 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $14 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Series D Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Kamran R. Najmabadi · Executive Officer Ramtin R. Agah · Executive Officer, Director Shaun R. Bagai · Executive Officer, Director Laurence J. Marton · Director Una S. Ryan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Shaun Bagai, Chief Exec. Officer. Source: SEC Form D, newest notice filed Jun 19, 2018. Read the notice at the SEC .
equity SEC Dec 2015 $2 M No. 2 $2 to $10 million 18
RenovoRx, Inc.: Raise no. 2, Dec 2015 × Investors in this round 18 investors had bought by the notice of Jan 5, 2016: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, other: Series C Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Kamran R. Najmabadi · Executive Officer Ramtin R. Agah · Executive Officer, Director Shaun R. Bagai · Executive Officer, Director Klaus R. Hambuechen · Director Laurence J. Marton · Director Una S. Ryan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Shaun Bagai, Chief Exec. Officer. Source: SEC Form D, newest notice filed Jan 5, 2016. Read the notice at the SEC .
equity SEC Dec 2013 $1 M No. 1 Under $2 million 11
RenovoRx, Inc.: Raise no. 1, Dec 2013 × Investors in this round 11 investors had bought by the notice of Dec 23, 2013: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered; $0 M still to sell
Smallest investment taken $25,000
What was sold equity, other: Series B Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Frank S. Rahmani · Executive Officer Kamran Gaia Najmabadi · Executive Officer Marta Gaia Zanchi, Ph.D. · Executive Officer, Director Klaus W. Hambuechen · Director Laurence J. Marton, M.D. · Director Ramtin Gaia Agah, M.D. · Director Una S. Ryan, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Marta Gaia Zanchi, Ceo. Source: SEC Form D, newest notice filed Dec 23, 2013. Read the notice at the SEC .
equity SEC